VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 32 filers reported holding VASCULAR BIOGENICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18 | +200.0% | 79,892 | +113.5% | 0.00% | 0.0% |
| Q1 2023 | $6 | 0.0% | 37,424 | -27.9% | 0.00% | 0.0% |
| Q4 2022 | $6 | -100.0% | 51,915 | -43.6% | 0.00% | 0.0% |
| Q3 2022 | $14,000 | -46.2% | 92,085 | +475.1% | 0.00% | -50.0% |
| Q2 2022 | $26,000 | +8.3% | 16,013 | +29.8% | 0.00% | 0.0% |
| Q4 2021 | $24,000 | -22.6% | 12,341 | -19.3% | 0.00% | -33.3% |
| Q3 2021 | $31,000 | -67.4% | 15,298 | -61.4% | 0.00% | -66.7% |
| Q2 2021 | $95,000 | +41.8% | 39,618 | -28.2% | 0.01% | -18.2% |
| Q3 2020 | $67,000 | +168.0% | 55,166 | +184.4% | 0.01% | +266.7% |
| Q2 2020 | $25,000 | +25.0% | 19,400 | +57.4% | 0.00% | +200.0% |
| Q3 2018 | $20,000 | -85.8% | 12,323 | -80.8% | 0.00% | -83.3% |
| Q2 2018 | $141,000 | -10.2% | 64,203 | -5.9% | 0.01% | -25.0% |
| Q1 2018 | $157,000 | – | 68,222 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,593,286 | $4,382,000 | 1.02% |
| Telemetry Investments, L.L.C. | 75,000 | $127,000 | 0.20% |
| Ikarian Capital, LLC | 830,747 | $1,404,000 | 0.18% |
| DLD Asset Management, LP | 550,000 | $930,000 | 0.06% |
| Phoenix Holdings Ltd. | 1,020,000 | $1,724,000 | 0.03% |
| Spectrum Planning & Advisory Services Inc. | 16,000 | $27,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 79,716 | $135,000 | 0.00% |
| HBK Sorce Advisory LLC | 22,325 | $38,000 | 0.00% |
| B. Riley Wealth Management, Inc. | 12,000 | $20,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,155 | $21,000 | 0.00% |